The European pharmaceutical analytical testing outsourcing market is estimated to grow at a CAGR of around 7.8% during the forecast period owing to the growing number of clinical trials in the region coupled with regulatory standards related to analytical testing in the region. Moreover, growing R&D and manufacturing in the pharmaceutical sector coupled with rising outsourcing services in the region are further projected to provide a significant opportunity to the market. The European market for pharmaceutical analytical testing outsourcing is classified on the basis of product type and services.
Based on the product type, the market is further classified into API, raw materials, and finished products. The API segment is projected to have considerable growth during the forecast period. Based on the services, the European pharmaceutical analytical testing outsourcing market is further segmented into Bioanalytical services, stability testing, drug substance, method development & validation, and others. Geographically, the European pharmaceutical analytical testing outsourcing market is further classified into UK, Germany, France, Italy, Spain, and the Rest of Europe. Among geography, UK is anticipated to hold a significant market share in the European pharmaceutical analytical testing outsourcing market.
Furthermore, the European pharmaceutical analytical testing outsourcing market is characterized by the presence of several market players that are catering to a wide range of customers across the globe. Some of the key players in the market include Eurofins GSC Lux SARL, Element Materials Technology Group Ltd., ICON plc, Intertek Group plc, SGS SA, and others. These players adopt various strategies to remain competitive in the market and gain a competitive advantage over other players operating in the market. Mergers and acquisitions, product launches, and partnerships and collaborations, and geographical expansion are some of the major activities adopted by the market players.
Research Methodology
The market study of the European pharmaceutical analytical testing outsourcing market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for pharmaceutical analytical testing outsourcing market players, pharmaceutical manufacturers, contract manufacturers, distributors & traders, industry associates & experts, government organizations, regulatory bodies, and other market participants for the overall market and competitive analysis. The report provides an in-depth analysis of market size, products offered by the companies, and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the European Pharmaceutical Analytical Testing Outsourcing Industry
• Recovery Scenario of the European Pharmaceutical Analytical Testing Outsourcing Industry
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.2. Key Strategy Analysis
3.3. Impact of COVID-19 on key players
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. European Pharmaceutical Analytical Testing Outsourcing Market by Product type
5.1.1. API
5.1.2. Raw Materials
5.1.3. Finished products
5.2. European Pharmaceutical Analytical Testing Outsourcing Market by Services
5.2.1. Bioanalytical services
5.2.2. Stability testing
5.2.3. Drug substance
5.2.4. Method development & Validation
5.2.5. Others (Quality Testing)
6. Regional Analysis
6.1. UK
6.2. Germany
6.3. France
6.4. Italy
6.5. Spain
6.6. Rest of Europe
7. Company Profiles
7.1. Charles River Laboratories International, Inc.
7.2. CMIC, Inc.
7.3. Cambrex Corp.
7.4. Covance Inc.
7.5. Eurofins GSC Lux SARL
7.6. Element Materials Technology Group Ltd.
7.7. ICON plc
7.8. Intertek Group plc
7.9. SGS SA
7.10. WuXiAppTec Co., Ltd.
1. EUROPEAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BYPRODUCT TYPE, 2020-2027 ($ MILLION)
2. EUROPEAN API MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
3. EUROPEAN RAW MATERIALS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
4. EUROPEAN FINISHED PRODUCTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
5. EUROPEAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY SERVICES, 2020-2027 ($ MILLION)
6. EUROPEAN BIO ANALYTICAL SERVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
7. EUROPEAN STABILITY TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
8. EUROPEAN DRUG SUBSTANCE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
9. EUROPEAN METHOD DEVELOPMENT & VALIDATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
10. EUROPEAN OTHERS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
11. EUROPEAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
12. UK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BYPRODUCT TYPE, 2020-2027 ($ MILLION)
13. UK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY SERVICES, 2020-2027 ($ MILLION)
14. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BYPRODUCT TYPE, 2020-2027 ($ MILLION)
15. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY SERVICES, 2020-2027 ($ MILLION)
16. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
17. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY SERVICES, 2020-2027 ($ MILLION)
18. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
19. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY SERVICES, 2020-2027 ($ MILLION)
20. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
21. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY SERVICES, 2020-2027 ($ MILLION)
22. REST OF EUROPE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
23. REST OF EUROPE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH AND ANALYSIS BY SERVICES, 2020-2027 ($ MILLION)
1. IMPACT OF COVID-19 ON EUROPEAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, 2020-2027 (% MILLION)
2. IMPACT OF COVID-19 ON EUROPEAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET BY SEGMENT, 2020-2027 (% MILLION)
3. RECOVERY OF EUROPEAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, 2020-2027 (%)
4. EUROPEAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE BYPRODUCT TYPE, 2020 VS 2027 (%)
5. EUROPEAN API ANALYTICAL TESTING OUTSOURCING MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
6. EUROPEAN RAW MATERIALS ANALYTICAL TESTING OUTSOURCING MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
7. EUROPEAN FINISHED PRODUCTS ANALYTICAL TESTING OUTSOURCING MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
8. EUROPEAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE BY SERVICES, 2020 VS 2027 (%)
9. EUROPEANBIOANALYTICAL SERVICES MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
10. EUROPEAN STABILITY TESTING MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
11. EUROPEAN DRUG SUBSTANCE MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
12. EUROPEAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
13. UK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2020-2027 ($ MILLION)
14. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2020-2027 ($ MILLION)
15. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2020-2027 ($ MILLION)
16. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2020-2027 ($ MILLION)
17. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2020-2027 ($ MILLION)
18. REST OF EUROPE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2020-2027 ($ MILLION)